Calidad de los ensayos clínicos sobre el glaucoma crónico [PDF]
, 2016 Introducción: El glaucoma crónico es el glaucoma más frecuente que se encuentra en la población, se caracteriza por una tensión ocular alta ya que se inicia por lo general con el aumento de la presión interna del ojo debido a un fallo de drenaje del ...
Pérez Cáceres, Ana R.
core
Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. [PDF]
, 2008 PURPOSE. To evaluate the effect of the timolol-dorzolamide fixed combination (TDFC) and latanoprost 0.005% on 24-hour intraocular pressure (IOP), systolic (SBP) and diastolic (DBP) blood pressure, and diastolic ocular perfusion pressure (DOPP) in ...
Floriani I. +4 more
core +1 more source
Retinocochleocerebral Vasculopathy Presented as Bilateral Neovascular Glaucoma
Clinical Case Reports, Volume 13, Issue 1, January 2025.ABSTRACT Susac is a rare systemic disease characterized by ischemic events involving the cochlea, brain, and retina. Delay in the diagnosis leads to sight‐threatening complications such as neovascular glaucoma.
Mehrdad Motamed Shariati +2 more
wiley +1 more source
Brimonidine as an additional treatment for moderate glaucoma [PDF]
РМЖ "Клиническая офтальмология", 2021 I.R. Gazizova1, V.E. Korelina2,3 1N.P. Bekhtereva Institute of the Human Brain, Saint Petersburg, Russian Federation 2LLC “American Medical Clinic”, Saint Petersburg, Russian Federation 3I.I.
I.R. Gazizova, V.E. Korelina
doaj
Magnetic Resonance Imaging of Optic Nerve Traction During Adduction in Primary Open-Angle Glaucoma With Normal Intraocular Pressure. [PDF]
, 2017 PurposeWe used magnetic resonance imaging (MRI) to ascertain effects of optic nerve (ON) traction in adduction, a phenomenon proposed as neuropathic in primary open-angle glaucoma (POAG).MethodsSeventeen patients with POAG and maximal IOP ≤ 20 mm Hg, and
Bonelli, Laura +8 more
core +1 more source
Brimonidine in the treatment of glaucoma and ocular hypertension
Therapeutics and Clinical Risk Management, 2006 Treatment in glaucoma aims to lower intraocular pressure (IOP) to reduce the risk of progression and vision loss. The alpha2-adrenergic receptor agonist brimonidine effectively lowers IOP and is useful as monotherapy, adjunctive therapy, and replacement therapy in open-angle glaucoma and ocular hypertension.
openaire +4 more sources
Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
Indian Journal of Ophthalmology, 2003 Purpose: To compare the short-term efficacy and safety of topical latanoprost and brimonidine in Indian eyes. Materials and Methods: Twenty-eight patients with ocular hypertension, primary open-angle, pseudoexfoliation or pigmentary glaucoma were ...
Thomas Ravi +5 more
doaj
Effect of a fixed combination of ripasudil and brimonidine on aqueous humor dynamics in mice
Scientific ReportsRipasudil–brimonidine fixed-dose combination (K-232) simultaneously targets three different intraocular pressure (IOP) lowering mechanisms, increasing trabecular meshwork outflow and uveoscleral outflow, and reducing aqueous humor production Vascularly ...
Reiko Yamagishi-Kimura +2 more
doaj +1 more source
Effects of brimonidine 0.2% on blue‐yellow perimetry of glaucomatous patients [PDF]
, 1998 L. Mastropasqua +5 more
openalex +1 more source
Drug Delivery, 2019 Brimonidine tartrate (BRT) is a hydrophilic α2 adrenergic agonist used for the treatment of glaucoma. Glaucoma is an ocular disease affecting the anterior segment of the eye requiring lifetime treatment.
Alaa Emad Eldeeb, Salwa Salah, M. Ghorab
semanticscholar +1 more source